Tiziana's foralumab continues to be safe and well-tolerated, with no drug-related serious side effects after long-term use, ...
The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...
Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system attacks the body’s nerves. Immune cells ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...
The FDA rejected Sanofi's MS drug tolebrutinib, citing liver injury risks, unclear benefits, and trial data that failed to ...
Dr. Parisa Khosravi knows exactly what her patients are going through and the shock they might experience when she delivers the diagnosis. As a neuroimmunologist at Central Texas Neurology Consultants ...
A new study led by the University of Toronto (U of T) has discovered a possible biomarker linked to multiple sclerosis (MS) ...
A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback